MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Corvus Pharmaceuticals, Inc. (CRVS)
Corvus Pharmaceuticals, Inc. (CRVS)
source: myfinsight.com
Download
Download image
Comprehensive (gain) income
-$13,922K
Cumulative foreign
currency translation...
$104K
Net (gain) income
-$13,692K
Unrealized loss on
marketable securities
-$334K
Gain before equity
method investment
-$13,093K
Loss from equity
method investment
-$599K
Interest income and other
expense, net
$1,784K
Loss from operations
-$14,877K
Total operating
expenses
$14,877K
Research and development
$11,175K
General and
administrative
$3,702K
Back